+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetes Care Devices Market - Global Forecast 2026-2032- Product Image
Diabetes Care Devices Market - Global Forecast 2026-2032- Product Image
New

Diabetes Care Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5311206
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

As digital health and regulatory evolution accelerate, senior leaders face a dynamic diabetes care devices market shaped by clinical advancements and operational complexities. It is crucial for decision-makers to identify emerging opportunities, manage risks, and align strategies for evolving standards in patient management.

Market Snapshot: Diabetes Care Devices Market

In 2025, the global diabetes care devices market reached USD 32.18 billion and is projected to rise to USD 36.34 billion by 2026. Carrying a CAGR of 13.42%, forecasts estimate the market’s value will reach USD 77.72 billion by 2032.

Scope & Segmentation: Strategic Overview for Senior Decision-Makers

This report provides a thorough analysis of the diabetes care devices sector, centering on market-defining segments and technological drivers influencing each global region. The segmentation offers tactical insights to support investment, procurement, and partnership decisions.

  • Device Types: Artificial Pancreas Systems (Full Closed Loop, Hybrid Closed Loop), Glucose Monitoring Devices (Continuous, Flash, Self-Monitoring Blood Glucose), Injection Aids (Infusion Sets, Pen Needles, Syringe Needles), Insulin Pens (Prefilled Disposable, Reusable, Smart Pens), Insulin Pumps (Patch, Tubed), and Insulin Syringes. Each device type reflects distinct clinical roles and design requirements, affecting patient engagement and therapeutic pathways.
  • Technology Platforms: Continuous Glucose Monitoring (Real Time, Retrospective), Flash Glucose Monitoring, and Self-Monitoring Blood Glucose (Glucose Meters, Lancets, Test Strips) are reviewed, focusing on their role in advancing care protocols and navigating reimbursement environments.
  • Delivery Modes: Continuous and Intermittent Delivery highlight differences in adherence profiles and device design, impacting clinical workflows and patient preferences.
  • Insulin Formulations: Intermediate Acting, Long Acting (Detemir, Glargine), Rapid Acting (Aspart, Glulisine, Lispro), Short Acting, and Ultra Long Acting are analyzed, with attention to their compatibility across device platforms and implications for therapy optimization.
  • Distribution Channels: Direct Sales, Hospital Pharmacies, Online Channels, Retail Pharmacies (Chain and Independent) illustrate the evolving access pathways and procurement models throughout the value chain.
  • End Users: Diagnostic Centers, Home Care, Hospitals and Clinics (Diabetes Clinics, General Clinics) define the principal sources of clinical demand and influence procurement and adoption strategies.
  • Geographies: Americas, Europe, Middle East & Africa, and Asia-Pacific, each marked by unique reimbursement systems, regulatory factors, and patterns of technology adoption, underpin tailored market-entry and growth plans.

Key Takeaways: Strategic Insights for the Diabetes Care Devices Market

  • Advances in digital and device technology are driving a transition from episodic, clinic-based interventions to seamless, self-managed care, enhancing patient autonomy and data integration.
  • Developments in device interoperability, patient-centric interfaces, and intelligent delivery mechanisms are enabling new industry models focused on outcomes and expanded use of remote monitoring solutions.
  • Manufacturers are realigning product portfolios in response to shifts in the regulatory landscape and increasing demand for real-world clinical evidence, which is influencing payer and provider expectations for clinical effectiveness.
  • The rising need for digital convergence is shaping modular device ecosystems, supporting adherence and integration with cloud-based analytics that enhance clinical decision-making and operational efficiency.
  • Regional differences in reimbursement, healthcare systems, and regulatory requirements create complex go-to-market considerations and necessitate adaptive adoption strategies for success across markets.
  • Optimizing distribution channels and leveraging strong partner networks support robust procurement, device supply reliability, and measurable impacts on care delivery quality.

Tariff Impact: Navigating Supply Chain and Procurement Risks

Recent tariffs, particularly in the US, have intensified complexity within diabetes care device supply chains. Organizations are responding by diversifying suppliers, exploring nearshoring, and improving transparency in country-of-origin reporting. Procurement teams are negotiating long-term supplier agreements with cost-of-ownership provisions to control margin pressures while ensuring steady device availability. Prioritizing resilience planning and flexible sourcing remains vital, especially for devices dependent on imported or proprietary components.

Methodology & Data Sources

The research methodology combines semi-structured interviews with senior stakeholders—including endocrinologists, nurses, procurement leads, and executives—with an exhaustive review of clinical literature, regulatory filings, and policy documents. Triangulation improves data reliability, with comprehensive methodological details and limitations provided in the appendices to ensure clarity and actionable insight.

Why This Report Matters: Actionable Value for Strategic Leaders

  • Uncover priority areas for investment and innovation by analyzing interactions across clinical, regulatory, and commercial domains in diabetes care devices.
  • Enhance procurement and partnership strategies with actionable, regionally grounded segmentation insights that inform channel optimization and market positioning.
  • Support executive decisions with robust real-world evidence, enabling scalable and differentiated product deployments aligned with evolving care and operational standards.

Conclusion

The diabetes care devices market is at a pivotal juncture, defined by evolving technologies, regulatory shifts, and new operational demands. Strategic alignment with these insights will position leaders to prioritize adoption, optimize care delivery, and drive sustainable stakeholder value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Diabetes Care Devices Market, by Device Type
8.1. Artificial Pancreas Systems
8.1.1. Full Closed Loop
8.1.2. Hybrid Closed Loop
8.2. Glucose Monitoring Devices
8.2.1. Continuous Glucose Monitoring
8.2.2. Flash Glucose Monitoring
8.2.3. Self Monitoring Blood Glucose
8.3. Injection Aids
8.3.1. Infusion Sets
8.3.2. Pen Needles
8.3.3. Syringe Needles
8.4. Insulin Pens
8.4.1. Prefilled Disposable Pens
8.4.2. Reusable Pens
8.4.3. Smart Pens
8.5. Insulin Pumps
8.5.1. Patch Pumps
8.5.2. Tubed Pumps
8.6. Insulin Syringes
9. Diabetes Care Devices Market, by Technology
9.1. Continuous Glucose Monitoring
9.1.1. Real Time Continuous Glucose Monitoring
9.1.2. Retrospective Continuous Glucose Monitoring
9.2. Flash Glucose Monitoring
9.3. Self Monitoring Blood Glucose
9.3.1. Glucose Meters
9.3.2. Lancets
9.3.3. Test Strips
10. Diabetes Care Devices Market, by Delivery Mode
10.1. Continuous Delivery
10.2. Intermittent Delivery
11. Diabetes Care Devices Market, by Insulin Type
11.1. Intermediate Acting
11.2. Long Acting
11.2.1. Detemir
11.2.2. Glargine
11.3. Rapid Acting
11.3.1. Aspart
11.3.2. Glulisine
11.3.3. Lispro
11.4. Short Acting
11.5. Ultra Long Acting
12. Diabetes Care Devices Market, by Distribution Channel
12.1. Online Channels
12.2. Offline
12.2.1. Retail Pharmacies
12.2.2. Hospital Pharmacies
13. Diabetes Care Devices Market, by End User
13.1. Diagnostic Centers
13.2. Home Care
13.3. Hospitals And Clinics
13.3.1. Diabetes Clinics
13.3.2. General Clinics
14. Diabetes Care Devices Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Diabetes Care Devices Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Diabetes Care Devices Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Diabetes Care Devices Market
18. China Diabetes Care Devices Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Acon Laboratories Inc.
19.7. ARKray Inc.
19.8. Ascensia Diabetes Care Holdings AG
19.9. B. Braun Melsungen AG
19.10. Becton Dickinson and Company BD
19.11. Bionime Corporation
19.12. Dexcom Inc.
19.13. Eli Lilly and Company
19.14. F. Hoffmann-La Roche Ltd.
19.15. Insulet Corporation
19.16. LifeScan Inc.
19.17. Medtronic plc
19.18. Menarini Diagnostics
19.19. MicroTech Medical Inc.
19.20. Nipro Corporation
19.21. Novo Nordisk A/S
19.22. Sanofi
19.23. Senseonics Holdings Inc.
19.24. Sinocare
19.25. Tandem Diabetes Care Inc.
19.26. Terumo Corporation
19.27. Trividia Health
19.28. Valeritas Holdings Inc.
19.29. Ypsomed Holding AG
List of Figures
FIGURE 1. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FULL CLOSED LOOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FULL CLOSED LOOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FULL CLOSED LOOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HYBRID CLOSED LOOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HYBRID CLOSED LOOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HYBRID CLOSED LOOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INFUSION SETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PEN NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PEN NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PREFILLED DISPOSABLE PENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PREFILLED DISPOSABLE PENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PREFILLED DISPOSABLE PENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REUSABLE PENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REUSABLE PENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REUSABLE PENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SMART PENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SMART PENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SMART PENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REAL TIME CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REAL TIME CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REAL TIME CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE METERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE METERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TEST STRIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TEST STRIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMITTENT DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMITTENT DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMITTENT DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMEDIATE ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMEDIATE ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMEDIATE ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DETEMIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DETEMIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DETEMIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLARGINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLARGINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLARGINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ASPART, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ASPART, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ASPART, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLULISINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLULISINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLULISINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LISPRO, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LISPRO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LISPRO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SHORT ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SHORT ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ULTRA LONG ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ULTRA LONG ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ULTRA LONG ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIABETES CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIABETES CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 236. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 238. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 239. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 240. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 241. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 242. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 243. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 245. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 246. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 247. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 248. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 249. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 250. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 251. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 252. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 258. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 272. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 274. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 275. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 276. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 277. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 278. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 279. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 280. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 281. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 282. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 283. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 284. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 285. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 286. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 287. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 288. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 290. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 292. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2032 (USD MILLION)
TABLE 293. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 294. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
TABLE 297. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2032 (USD MILLION)
TABLE 299. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2032 (USD MILLION)
TABLE 300. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 301. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 302. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
TABLE 304. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 305. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 306. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 307. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 308. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 309. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 310. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD

Companies Mentioned

The key companies profiled in this Diabetes Care Devices market report include:
  • Abbott Laboratories
  • Acon Laboratories Inc.
  • ARKray Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Becton Dickinson and Company BD
  • Bionime Corporation
  • Dexcom Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Menarini Diagnostics
  • MicroTech Medical Inc.
  • Nipro Corporation
  • Novo Nordisk A/S
  • Sanofi
  • Senseonics Holdings Inc.
  • Sinocare
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Trividia Health
  • Valeritas Holdings Inc.
  • Ypsomed Holding AG

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.34 Billion
Forecasted Market Value ( USD ) by 2032 $ 77.72 Billion
Compound Annual Growth Rate13.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Diabetes Care Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, End User, and Region, 2025-2033 - Product Image

Diabetes Care Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, End User, and Region, 2025-2033

  • Report
  • 149 Pages
  • Global
From
Diabetes Care Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Diabetes Care Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 134 Pages
  • Global
From
Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030 - Product Image

Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030

  • Report
  • 304 Pages
  • Global
From
Diabetes Care Devices - Global Strategic Business Report - Product Image

Diabetes Care Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Diabetes Care Devices: Market Share, and Growth Analysis by Type, Type of Expenditure, Product, Type of Testing - Product Image

Diabetes Care Devices: Market Share, and Growth Analysis by Type, Type of Expenditure, Product, Type of Testing

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.